BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Jacobio Gains China CDE Approval for Phase III SHP2 and KRAS G12C Inhibitor Trial

This approved study in China is a randomized active controlled phase III trial design to evaluate the efficacy and safety of JAB-3312 in combinat...

February 19, 2024 | News

AstraZeneca's TAGRISSO® (osimertinib) with Chemotherapy Approved in the US for EGFR-Mutated Advanced Lung Cancer

AstraZeneca’s TAGRISSO® (osimertinib) with the addition of chemotherapy has been approved in the US for the treatment of adult patients with...

February 17, 2024 | News

PharusDx Secures Exclusive License for Breakthrough Pancreatic Cancer Biomarkers from City of Hope

Pharus Diagnostics ("PharusDx") has announced a global exclusive license agreement with City of Hope cancer center for proprietary biomarkers to be...

February 16, 2024 | News

SOPHiA GENETICS Expands Program with AstraZeneca Spain to Enhance Access to HRD Testing Across Spain

Originally launched in 2022, the collaboration between SOPHiA GENETICS and AstraZeneca Spain established HRD testing in five labs across the countr...

February 08, 2024 | News

Telix to Acquire QSAM Biosciences, Bolstering Bone Cancer Targeting

153Sm-DOTMP utilizes a cutting-edge chelating agent to deliver Samarium-153 radioisotope, offering potential advancements in bone cancer treatment....

February 08, 2024 | News

World Cancer Day 2024: WHO Regional Director Urges Collective Action for a Cancer-Free Africa

The cancer situation in Africa is alarming, with 1.1 million new cases and 700,000 deaths in 2020. Breast, cervical, prostate, colorectal, and live...

February 04, 2024 | News

DELFi Diagnostics Launches Fragmentome-Based Cancer Treatment Monitoring Assay

DELFI Diagnostics, Inc., a developer of accessible blood-based tests that deliver a new way to enhance cancer detection, announced availability of the comp...

February 04, 2024 | News

ASPIRE Consortium Tackles Rising Lung Cancer in Asia-Pacific

Lung cancer has a significant health and economic impact in the region. It is the most prevalent cancer, accounting for about 1 million deaths per year, an...

February 04, 2024 | News

Genmab and Pfizer Announce European Medicines Agency Validation for Tisotumab Vedotin in Cervical Cancer

Genmab A/S (Nasdaq: GMAB) and Pfizer, Inc. (NYSE: PFE) have reported that the European Medicines Agency (EMA) has validated the marketing authorization app...

February 02, 2024 | News

RemeGen Spotlights Three Major Advances in Global Cancer Battle, Closing Care Gap

Dr. Jianmin Fang, CEO of RemeGen, commented, "Cancer is the common enemy of mankind, and at RemeGen we feel a strong sense of responsibility and missi...

February 02, 2024 | News

QIAGEN Digital Insights Introduces Rapid NGS Analysis for Somatic Cancer

New software accelerator significantly reduces time and cost of NGS secondary analysis for somatic cancer, analyzing a 275-gene comprehensive cancer pane...

February 02, 2024 | News

Biosyngen's BST02 Granted FDA Fast Track for Liver Cancer Treatment

Fast track is a process designed to facilitate development, and accelerate the review of drugs to treat serious or life-threatening conditions and fill an ...

February 02, 2024 | News

Agilent and Incyte Team Up for Advanced Diagnostics in Hematology & Oncology

The value of the companion diagnostics market is predicted to expand to nearly US $14B by 2030, driven in part by the power of these tests to inform t...

February 01, 2024 | News

CellVax Therapeutics Receives FDA Clearance for FK-PC101 Cancer Immunotherapy IND

FK-PC101 is CellVax's novel personalized cancer immunotherapy intended to treat prostate cancer patients who have a high risk of recurrence after prostatec...

January 30, 2024 | News

Stay Connected